LONDON - Advanced trials of a new mosquito medicine that began in Africa last week could lead to the world's first malaria vaccine becoming available as soon as 2011, a newspaper reported on Monday.
GlaxoSmithKline (GSK) began Phase-III trials of its Mosquirix medicine on Wednesday as scientists began injecting 1,200 infants and children in the town of Bagamoyo in Tanzania.
Eventually, up to 16,000 patients will be immunised in seven African countries, including Mozambique, Kenya and Malawi. .
Click here to read the entire story.
Latest from Pest Control Technology
- TAP Showcases Unique EPA-Registered Insulation Solution
- Atticus' Growing Pest Management Product Portfolio
- Bobby Jenkins Named the 2025 Crown Lifetime Achievement Award Recipient
- Abell Pest Control Marks Five Years of ‘12 Days of Giving’
- Built-by-Owner Home? Look for Surprises
- The Pest Rangers Acquires O.C.E. Pest & Termite Control
- The Professional Pest Management Alliance Expands Investor Network
- Big Blue Bug Solutions’ Holiday Lighting Event Sets New Viewership Record
